Lilia-Celine Lozada
Stock Analyst at JP Morgan
(1.61)
# 3,214
Out of 5,182 analysts
9
Total ratings
40%
Success rate
3.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $22 → $26 | $26.49 | -1.85% | 2 | Feb 6, 2026 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $28.46 | +68.66% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $11.78 | +1.87% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $1.91 | +161.78% | 2 | Nov 7, 2025 |
Envista Holdings
Feb 6, 2026
Maintains: Neutral
Price Target: $22 → $26
Current: $26.49
Upside: -1.85%
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $28.46
Upside: +68.66%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $11.78
Upside: +1.87%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $1.91
Upside: +161.78%